Research Associate
Matthew currently works on the development of a sensitive assay for early diagnosis of neurodegenerative diseases from blood serum. He completed his PhD at the University of Leeds in 2012 with Prof. Steve Evans, looking at the manipulation of lipid membranes with electric fields. After this, he worked as a postdoctoral researcher at the University of Oxford in 2013 (and King's College London in 2016) with Prof. Mark Wallace, developing model lipid membrane systems to better understand anomalous diffusion. He then moved to the University of Cambridge in 2018 to develop plasmonic sensing platforms for lipid membranes with Prof. Jeremy Baumberg, before joining the Klenerman Lab in 2020.